Investors expect the company to underperform the broader industry, leading to a low P/S ratio. The company's declining revenues and the industry's projected 25% growth could further decrease the P/S ratio if top-line growth doesn't improve.

Investors may believe CGN Nuclear Technology Development will underperform the broader industry, contributing to its low P/S ratio. The company's declining medium-term revenue is a key factor. If these trends continue, the share price may not move significantly in either direction soon.

The company's balance sheet is solid with liabilities nearly equal to liquid assets. However, negative EBIT and a 44% revenue drop last year raise debt serviceability concerns. Its balance sheet is a bit strained and its debt usage is considered risky.